Ke Tang

1.8k citations
54 papers · 1.2k indexed · h-index 20
Topics
RNA and protein synthesis mechanisms (7 papers)RNA Research and Splicing (7 papers)Chromatin Remodeling and Cancer (4 papers)

In The Last Decade

Ke Tang

52 papers receiving 1.2k citations

Peers

Ke Tang
Comparison fields: 5 of 114
  • Molecular Biology 810
  • Cancer Research 410
  • Oncology 212
  • Immunology 98
  • Surgery 95
Replace Yiping Qu with:
Yiping Qu China
Joseph R. Dynlacht United States
Naz Chaudary Canada
Xiangjun Meng China
Laure Marignol Ireland
Xiaojie Li China
Heng Liu China
Gang Ning United States
Ahmad Salameh United States
Clifton Stephens United States
Ke Tang relative to Yiping Qu China Yiping Qu's profile →
Citations per field
00.5×1.5×
Yiping Qu · 1×
Citations per year

Countries citing papers authored by Ke Tang

Since Specialization
Citations

This map shows the geographic impact of Ke Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Tang more than expected).

Fields of papers citing papers by Ke Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Tang. The network helps show where Ke Tang may publish in the future.

Co-authorship network of co-authors of Ke Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Tang. A scholar is included among the top collaborators of Ke Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Tang. Ke Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 7
3 4
4 13
5 25
6 4
7 22
8 50
9 53
10 11
11 12
12 23
13 47
14 59
15 19
16
Role of NGX6 in nasopharyngeal carcinoma with high ability of metastasis cell line 5--8F
1
17 5
18
Expression of LRRC4 has the potential to decrease the growth rate and tumorigenesis of glioblastoma cell line U251.
9
19 74
20 10

About Ke Tang

Ke Tang is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (7 papers), RNA Research and Splicing (7 papers) and Chromatin Remodeling and Cancer (4 papers). The work is most often cited by research in Cancer Research (410 citations), Molecular Biology (810 citations) and Oncology (212 citations). Ke Tang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Guiyuan Li, Zhaoyang Zeng, Yanhong Zhou, Wenling Zhang, Xiaoling Li, Shourong Shen, Cao Li, Wei Xiong, Jie Liang and Songqing Fan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026